PRESS RELEASE published on 02/29/2024 at 22:05, 2 years 1 month ago Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
PRESS RELEASE published on 02/14/2024 at 13:30, 2 years 1 month ago Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023 Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
PRESS RELEASE published on 12/21/2023 at 14:00, 2 years 3 months ago Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
PRESS RELEASE published on 12/14/2023 at 22:15, 2 years 3 months ago Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRESS RELEASE published on 10/31/2023 at 12:30, 2 years 5 months ago Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
PRESS RELEASE published on 10/25/2023 at 13:30, 2 years 5 months ago Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 5 months ago Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
PRESS RELEASE published on 09/20/2023 at 13:30, 2 years 6 months ago Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
Published on 04/07/2026 at 09:30, 20 minutes ago Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
Published on 04/07/2026 at 09:05, 45 minutes ago BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Published on 04/07/2026 at 09:01, 49 minutes ago Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
Published on 04/07/2026 at 08:00, 1 hour 50 minutes ago Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
Published on 04/07/2026 at 00:02, 9 hours 48 minutes ago Evergold Announces Closing of $5.4 Million Non-Brokered Private Placement
Published on 04/07/2026 at 09:13, 36 minutes ago Apprenticeship 2026: Entry-level salaries reflect economic change
Published on 04/07/2026 at 09:11, 38 minutes ago Huge land holdings, promising drill results: An exciting new gold story is unfolding in Liberia
Published on 04/07/2026 at 09:00, 49 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 04/07/2026 at 08:30, 1 hour 20 minutes ago Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:30, 1 hour 20 minutes ago Edenred obtient la note « A » au CDP et rejoint les leaders mondiaux engagés pour le climat
Published on 04/07/2026 at 08:00, 1 hour 50 minutes ago Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Published on 04/07/2026 at 08:00, 1 hour 50 minutes ago Un pacte mondial annoncé lors du G7 One Health Summit pour accélérer l'accès aux diagnostics face aux menaces sanitaires croissantes
Published on 04/06/2026 at 15:00, 18 hours 50 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality